- Recent Funding
- Investors
- Soleus Capital
Soleus Capital portfolio
Soleus Capital has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
It is a venture capital firm based in Greenwich, US. Its most recent investment on record is Star Therapeutics's $200M Series B+ round in October 2026, alongside Redmile Group, Janus Henderson Investors, OrbiMed and 6 others. By category, its portfolio leans toward Health and bio (4). It has co-invested with RA Capital Management, Redmile Group and New Leaf Venture Partners, most often RA Capital Management (7 rounds).
About Soleus Capital
What Soleus Capital invests in
- Health and bio · 4 · 100%
Soleus Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $200M | Redmile Group, Janus Henderson Investors (lead), OrbiMed (lead) +6 | ||
| Series B+ · $66M | Redmile Group, NEA, Samsara Biocapital +6 | ||
| Series B+ · $125M | Viking Global Investors (lead), Redmile Group, Qatar Investment Authority +6 | ||
| Series B+ · $200M | Redmile Group, NEA (lead), Mass General Brigham Ventures +5 | ||
| Series B+ | General Equity Holdings (lead), Riverhorse Investments, Steadview Capital +6 | ||
| Series B+ · $225M | Biotechnology Value Fund (lead), Blackstone, Cormorant Asset Management +3 | ||
| Series B+ · $90M | Redmile Group, Qatar Investment Authority, OrbiMed +6 | ||
| Series B+ · $155M | Redmile Group (lead), Mass General Brigham Ventures, Eurofarma +6 |
How Soleus Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 8 100% | $1.06B |
Soleus Capital portfolio companies
SStar Therapeutics$200MSeries B+ · Oct 2026
AAbcuro$66MSeries B+ · Aug 2026
PPrecision NeuroscienceSeries B+ · Nov 2024
AAltruBio$225MSeries B+ · May 2024
| Company | Round with Soleus Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $200M | $415M | Oct 23, 2026 Series B+ |
Health and bio |
Series B+ · $66M | $463M | Aug 18, 2026 Series B+ |
Health and bio |
Series B+ | $303M | Sep 24, 2026 Series B+ |
Health and bio |
Series B+ · $225M | $288M | May 21, 2024 Series B+ |
Most frequent co-investors
RRA Capital Management7 shared rounds · last Oct 23, 2026
RRedmile Group6 shared rounds · last Oct 23, 2026
NNew Leaf Venture Partners5 shared rounds · last Oct 23, 2026
SSanofi Ventures4 shared rounds · last Aug 18, 2026
OOrbiMed3 shared rounds · last Oct 23, 2026
SSofinnova Partners3 shared rounds · last Oct 23, 2026
NNYBC Ventures3 shared rounds · last Oct 23, 2026
SSamsara Biocapital3 shared rounds · last Aug 18, 2026
PPontifax3 shared rounds · last Aug 18, 2026
CCormorant Asset Management2 shared rounds · last Oct 23, 2026
NNEA2 shared rounds · last Aug 18, 2026
QQatar Investment Authority2 shared rounds · last Oct 1, 2025
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 8 rounds on Recent Funding that name Soleus Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Soleus Capital, which is a subset of its real portfolio. API: /api/v1/investors/soleus-capital (get a free API key). More: the most active VC firms and new venture capital funds.